Pages that link to "Q35231660"
Jump to navigation
Jump to search
The following pages link to Androgens and estrogens in benign prostatic hyperplasia: Past, present and future (Q35231660):
Displaying 50 items.
- Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction (Q24186736) (← links)
- Apoptotic Pathways Linked to Endocrine System as Potential Therapeutic Targets for Benign Prostatic Hyperplasia (Q26741226) (← links)
- Testosterone and benign prostatic hyperplasia (Q26863719) (← links)
- Xenotransplantation models to study the effects of toxicants on human fetal tissues (Q27013024) (← links)
- Bisphenol a and reproductive health: update of experimental and human evidence, 2007-2013 (Q28391779) (← links)
- Towards engineering hormone-binding globulins as drug delivery agents (Q28545213) (← links)
- Testosterone and 17β-estradiol induce glandular prostatic growth, bladder outlet obstruction, and voiding dysfunction in male mice (Q30525673) (← links)
- Aberrant Transforming Growth Factor-β Activation Recruits Mesenchymal Stem Cells During Prostatic Hyperplasia (Q33722426) (← links)
- Compounds from Cynomorium songaricum with Estrogenic and Androgenic Activities Suppress the Oestrogen/Androgen-Induced BPH Process (Q33735698) (← links)
- Finasteride treatment alters tissue specific androgen receptor expression in prostate tissues. (Q34064040) (← links)
- Personalized medicine for the management of benign prostatic hyperplasia (Q34084593) (← links)
- Surgical intervention for symptomatic benign prostatic hyperplasia is correlated with expression of the AP-1 transcription factor network (Q34163024) (← links)
- Safety and tolerability of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN). (Q34323757) (← links)
- Mechanisms of synergism between antagonists of growth hormone-releasing hormone and antagonists of luteinizing hormone-releasing hormone in shrinking experimental benign prostatic hyperplasia (Q34529072) (← links)
- Bisphenol A exposure during adulthood alters expression of aromatase and 5α-reductase isozymes in rat prostate (Q34584590) (← links)
- Maturation of the developing human fetal prostate in a rodent xenograft model (Q34987740) (← links)
- The in vitro and in vivo anti-cancer activities of a standardized quassinoids composition from Eurycoma longifolia on LNCaP human prostate cancer cells (Q35234916) (← links)
- Increased infiltrated macrophages in benign prostatic hyperplasia (BPH): role of stromal androgen receptor in macrophage-induced prostate stromal cell proliferation (Q36003050) (← links)
- Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia (BPH) development (Q36279487) (← links)
- Activation of innate anti-viral immune response genes in symptomatic benign prostatic hyperplasia (Q36331201) (← links)
- Estrogens and Male Lower Urinary Tract Dysfunction (Q36518535) (← links)
- The Predominant Proteins that React to the MC-20 Estrogen Receptor Alpha Antibody Differ in Molecular Weight between the Mammary Gland and Uterus in the Mouse and Rat. (Q36735733) (← links)
- Action Mechanism of Ginkgo biloba Leaf Extract Intervened by Exercise Therapy in Treatment of Benign Prostate Hyperplasia (Q36838223) (← links)
- Effects of Transdermal Testosterone Gel or an Aromatase Inhibitor on Prostate Volume in Older Men (Q36935566) (← links)
- In Utero and Lactational TCDD Exposure Increases Susceptibility to Lower Urinary Tract Dysfunction in Adulthood (Q36987154) (← links)
- Differential expression of androgen, estrogen, and progesterone receptors in benign prostatic hyperplasia (Q37161245) (← links)
- Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase. (Q37195621) (← links)
- Alcohol exposure in utero increases susceptibility to prostate tumorigenesis in rat offspring (Q37265869) (← links)
- Renal capsule xenografting and subcutaneous pellet implantation for the evaluation of prostate carcinogenesis and benign prostatic hyperplasia. (Q37377598) (← links)
- Benign prostatic hyperplasia: a new metabolic disease of the aging male and its correlation with sexual dysfunctions. (Q37618958) (← links)
- A possible relationship between serum sex hormones and benign prostatic hyperplasia/lower urinary tract symptoms in men who underwent transurethral prostate resection (Q37644679) (← links)
- CD8 T cells promote proliferation of benign prostatic hyperplasia epithelial cells under low androgen level via modulation of CCL5/STAT5/CCND1 signaling pathway (Q37652222) (← links)
- Selective estrogen receptor modulators for BPH: new factors on the ground. (Q38115066) (← links)
- Benign prostatic hyperplasia: a new metabolic disease? (Q38181426) (← links)
- Hormonal manipulation of lower urinary tract symptoms secondary to benign prostatic obstruction (Q38205422) (← links)
- Fetal alcohol exposure increases susceptibility to carcinogenesis and promotes tumor progression in prostate gland (Q38271804) (← links)
- Stromal androgen receptor roles in the development of normal prostate, benign prostate hyperplasia, and prostate cancer (Q38272331) (← links)
- De novo steroid biosynthesis in human prostate cell lines and biopsies (Q38796893) (← links)
- Endocrine control of benign prostatic hyperplasia. (Q38811041) (← links)
- Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: a role for GPR30/GPER? (Q39095837) (← links)
- Female prostate: historical, developmental, and morphological perspectives (Q39161021) (← links)
- Waist circumference is superior to weight and BMI in predicting sexual symptoms, voiding symptoms and psychosomatic symptoms in men with hypogonadism and erectile dysfunction (Q39613592) (← links)
- Correlation between prostate volume and single nucleotide polymorphisms implicated in the steroid pathway (Q39699530) (← links)
- Inhibitory effects of Ponciri Fructus on testosterone-induced benign prostatic hyperplasia in rats. (Q41247167) (← links)
- Antrodan, a β-glucan obtained from Antrodia cinnamomea mycelia, is beneficial to benign prostate hyperplasia (Q41653977) (← links)
- Specific deletion of LKB1/Stk11 in the Müllerian duct mesenchyme drives hyperplasia of the periurethral stroma and tumorigenesis in male mice (Q41677991) (← links)
- Age-related histological and zinc content changes in adult nonhyperplastic prostate glands (Q41788361) (← links)
- The traditional Korean herbal medicine Ga-Gam-Nai-Go-Hyan suppresses testosterone-induced benign prostatic hyperplasia by regulating inflammatory responses and apoptosis (Q42059249) (← links)
- Protective effect of tadalafil on the functional and structural changes of the rat ventral prostate caused by chronic pelvic ischemia (Q42200788) (← links)
- Antagonists of growth hormone-releasing hormone inhibit proliferation induced by inflammation in prostatic epithelial cells (Q42321749) (← links)